Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Indices rise and fall as growth, inflation, and risk appetite shift; news and expectations reshape valuation baselines and asset flows.
21,301 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A leading U.S. health care powerhouse is quietly building an AI-driven engine that touches every corner of its busine...
This article breaks down the expected path for synopsys (snps) 2026 earnings, focusing on AI design driver demand, li...
A sharp intraday move in uranium miners has investors asking what really sparked the rally. This article dives into t...
Investors ditching magnificent group are chasing a fresh AI-led cohort dubbed MANGOS, with Meta, Alphabet and NVIDIA ...
Prediction markets offer a different lens on big corporate moves. Discover what kalshi traders chance spacex says abo...
A biotech growth stock has surged 70% this year as it heads into pivotal phase 3 data and regulatory steps. Here’s wh...
A renewed uptrend in Bloom Energy stock has caught investors’ attention. This analysis breaks down the why, how it co...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
Two dividend stocks double right now can help steady your income while you grow wealth. We break down two dependable ...
CAVA Group's shares jumped on expansion progress, signaling investor enthusiasm for growth. This article breaks down ...
As 2026 unfolds, a fresh wave of growth stocks could power bigger gains for patient investors. This article highlight...